- Home
- ATAI vs RIV Comparison
ATAI vs RIV Comparison
Compare ATAI & RIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.84
Company Overview
Basic Information| Metric | ATAI | RIV |
|---|---|---|
| Founded | 2018 | 2015 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 323.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ATAI | RIV |
|---|---|---|
| Price | $3.84 | $11.71 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.33 | N/A |
| AVG Volume (30 Days) | ★ 3.3M | 87.6K |
| Earning Date | 11-12-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.85% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,018,000.00 | N/A |
| Revenue This Year | $943.18 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 811.78 | N/A |
| 52 Week Low | $1.15 | $9.63 |
| 52 Week High | $6.75 | $12.43 |
Technical Indicators
Market Signals| Indicator | ATAI | RIV |
|---|---|---|
| Relative Strength Index (RSI) | 40.53 | 50.17 |
| Support Level | $3.90 | $11.59 |
| Resistance Level | $4.72 | $11.85 |
| Average True Range (ATR) | 0.26 | 0.13 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 8.59 | 40.91 |
Price Performance
Historical Comparison ATAI
RIV
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.
About RIV RiverNorth Opportunities Fund Inc.
Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.